Freedom Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-17,184
| Closed | -$1.91M | – | 354 |
|
|
2025
Q2 | $1.91M | Sell |
17,184
-1,721
| -9% | -$183K | 0.15% | 111 |
|
|
2025
Q1 | $2.12M | Buy |
18,905
+7,894
| +72% | +$815K | 0.18% | 98 |
|
|
2024
Q4 | $1.02M | Sell |
11,011
-2,713
| -20% | -$244K | 0.08% | 231 |
|
|
2024
Q3 | $1.15M | Sell |
13,724
-1,659
| -11% | -$127K | 0.09% | 208 |
|
|
2024
Q2 | $1.06M | Buy |
15,383
+393
| +3% | +$26.2K | 0.09% | 222 |
|
|
2024
Q1 | $1.1M | Sell |
14,990
-1,780
| -11% | -$137K | 0.09% | 222 |
|
|
2023
Q4 | $1.36M | Sell |
16,770
-63
| -0.4% | -$4.9K | 0.11% | 171 |
|
|
2023
Q3 | $1.26M | Sell |
16,833
-1,929
| -10% | -$148K | 0.15% | 155 |
|
|
2023
Q2 | $1.45M | Sell |
18,762
-1,019
| -5% | -$81.3K | 0.16% | 153 |
|
|
2023
Q1 | $1.64M | Sell |
19,781
-4,297
| -18% | -$356K | 0.19% | 145 |
|
|
2022
Q4 | $2.07M | Buy |
24,078
+1,599
| +7% | +$127K | 0.23% | 106 |
|
|
2022
Q3 | $1.39M | Buy |
22,479
+554
| +3% | +$34.9K | 0.16% | 164 |
|
|
2022
Q2 | $1.36M | Sell |
21,925
-4,711
| -18% | -$292K | 0.14% | 193 |
|
|
2022
Q1 | $1.58M | Sell |
26,636
-37,638
| -59% | -$2.41M | 0.14% | 188 |
|
|
2021
Q4 | $4.67M | Sell |
64,274
-2,615
| -4% | -$180K | 0.34% | 58 |
|
|
2021
Q3 | $4.67M | Sell |
66,889
-1,290
| -2% | -$90.6K | 0.36% | 46 |
|
|
2021
Q2 | $4.7M | Sell |
68,179
-9,441
| -12% | -$630K | 0.35% | 50 |
|
|
2021
Q1 | $5.02M | Sell |
77,620
-3,081
| -4% | -$199K | 0.39% | 48 |
|
|
2020
Q4 | $4.7M | Buy |
80,701
+3,272
| +4% | +$197K | 0.52% | 41 |
|
|
2020
Q3 | $4.89M | Buy |
77,429
+7,392
| +11% | +$513K | 0.53% | 35 |
|
|
2020
Q2 | $5.39M | Sell |
70,037
-7,323
| -9% | -$561K | 0.59% | 28 |
|
|
2020
Q1 | $5.33M | Buy |
77,360
+6,835
| +10% | +$472K | 0.47% | 44 |
|
|
2019
Q4 | $4.58M | Buy |
70,525
+3,455
| +5% | +$225K | 0.4% | 51 |
|
|
2019
Q3 | $4.25M | Buy |
67,070
+943
| +1% | +$61.6K | 0.37% | 44 |
|
|
2019
Q2 | $4.47M | Sell |
66,127
-20,665
| -24% | -$1.36M | 0.37% | 47 |
|
|
2019
Q1 | $5.64M | Sell |
86,792
-2,476
| -3% | -$165K | 0.45% | 40 |
|
|
2018
Q4 | $5.58M | Sell |
89,268
-7,015
| -7% | -$490K | 0.43% | 31 |
|
|
2018
Q3 | $7.15M | Sell |
96,283
-8,572
| -8% | -$647K | 0.45% | 26 |
|
|
2018
Q2 | $7.43M | Buy |
104,855
+33,105
| +46% | +$2.34M | 0.45% | 28 |
|
|
2018
Q1 | $5.41M | Buy |
71,750
+7,249
| +11% | +$576K | 0.28% | 44 |
|
|
2017
Q4 | $4.62M | Sell |
64,501
-1,693
| -3% | -$129K | 0.24% | 44 |
|
|
2017
Q3 | $5.36M | Sell |
66,194
-1,506
| -2% | -$115K | 0.29% | 36 |
|
|
2017
Q2 | $4.79M | Buy |
67,700
+2,992
| +5% | +$199K | 0.27% | 38 |
|
|
2017
Q1 | $4.39M | Sell |
64,708
-5,442
| -8% | -$383K | 0.26% | 43 |
|
|
2016
Q4 | $5.02M | Sell |
70,150
-1,216
| -2% | -$90.4K | 0.32% | 36 |
|
|
2016
Q3 | $5.65M | Buy |
71,366
+897
| +1% | +$72.9K | 0.36% | 28 |
|
|
2016
Q2 | $5.88M | Buy |
70,469
+4,415
| +7% | +$392K | 0.4% | 22 |
|
|
2016
Q1 | $6.07M | Sell |
66,054
-11,729
| -15% | -$1.06M | 0.44% | 24 |
|
|
2015
Q4 | $7.87M | Buy |
77,783
+32,199
| +71% | +$3.35M | 0.6% | 16 |
|
|
2015
Q3 | $99K | Buy |
45,584
+20,112
| +79% | +$2.23M | 0.01% | 657 |
|
|
2015
Q2 | $2.98M | Buy |
25,472
+2,539
| +11% | +$277K | 0.31% | 43 |
|
|
2015
Q1 | $2.25M | Buy |
22,933
+6,391
| +39% | +$649K | 0.25% | 54 |
|
|
2014
Q4 | $1.56M | Buy |
16,542
+5,135
| +45% | +$531K | 0.2% | 70 |
|
|
2014
Q3 | $1.21M | Buy |
11,407
+527
| +5% | +$51.6K | 0.21% | 80 |
|
|
2014
Q2 | $902K | Buy |
10,880
+1,272
| +13% | +$99K | 0.15% | 106 |
|
|
2014
Q1 | $681K | Buy |
9,608
+1,788
| +23% | +$140K | 0.15% | 127 |
|
|
2013
Q4 | $587K | Buy |
7,820
+1,097
| +16% | +$76.4K | 0.15% | 129 |
|
|
2013
Q3 | $423K | Buy |
6,723
+1,581
| +31% | +$94.5K | 0.12% | 144 |
|
|
2013
Q2 | $264K | Buy |
+5,142
| New | +$268K | 0.09% | 209 |
|
Other funds holding GILD
Freedom Investment Management's GILD Position: Q3 2025 in Review
Freedom Investment Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 17,184 shares — an estimated $1.91M sold.
Freedom Investment Management first reported a position in GILD in Q2 2013 and held it in 49 quarters. The position peaked at $7.87M in Q4 2015. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Freedom Investment Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Freedom Investment Management sold 17,184 Gilead Sciences shares in Q3 2025, an estimated $1.91M.
- Freedom Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 49 quarters.
- Freedom Investment Management's Gilead Sciences position peaked at $7.87M in Q4 2015.
- 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.